Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

DDTに関する質問です.

G L Ross

    Lancet (London, England)
    |October 13, 2000
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Clinical significance of intra-nodal naevi in sentinel node biopsies for malignant melanoma.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
    Same author

    Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.

    Annals of the Royal College of Surgeons of England·2016
    Same author

    The Manchester guidelines for contralateral risk-reducing mastectomy.

    World journal of surgical oncology·2015
    Same author

    Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.

    International journal of surgical oncology·2015
    Same author

    Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.

    British journal of cancer·2014
    Same author

    Mastectomies of healthy, contralateral breasts in patients with breast cancer.

    British journal of hospital medicine (London, England : 2005)·2013
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る